Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/biomarker-endpoints-for-early-phase-cancer-prevention-studies-qzJ8V1u1h0
References (75)
-
D. Kossman, N. Williams, S. Domchek, M. Kurzer, Jill Stopfer, K. Schmitz (2011)
Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer.Journal of applied physiology, 111 6
-
Q. Khan, B. Kimler, Julie Clark, T. Metheny, C. Zalles, C. Fabian (2005)
Ki-67 Expression in Benign Breast Ductal Cells Obtained by Random Periareolar Fine Needle AspirationCancer Epidemiology Biomarkers & Prevention, 14
-
K. Crew, P. Brown, H. Greenlee, T. Bevers, B. Arun, C. Hudis, H. McArthur, Jenny Chang, M. Rimawi, L. Vornik, T. Cornelison, Antai Wang, H. Hibshoosh, Aqeel Ahmed, M. Terry, R. Santella, S. Lippman, D. Hershman (2012)
Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast CancerCancer Prevention Research, 5
-
A. Ryan, D. Berman, B. Nicklas, M. Sinha, R. Gingerich, G. Meneilly, J. Egan, D. Elahi (2003)
Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity.Diabetes care, 26 8
-
A. Wu, L. Butler (2011)
Green tea and breast cancer.Molecular nutrition & food research, 55 6
-
M. Becker, D. Yee (2001)
The IGF system and breast cancer.Endocrine-related cancer, 8 3
-
G. Maskarinec, M. Verheus, F. Steinberg, P. Amato, Margaret Cramer, Richard Lewis, Michael Murray, R. Young, W. Wong (2009)
Various doses of soy isoflavones do not modify mammographic density in postmenopausal women.The Journal of nutrition, 139 5
-
E. Bertone-Johnson, A. McTiernan, C. Thomson, J. Wactawski‐Wende, A. Aragaki, T. Rohan, M. Vitolins, R. Tamimi, K. Johnson, D. Lane, K. Rexrode, J. Peck, R. Chlebowski, G. Sarto, J. Manson (2012)
Vitamin D and Calcium Supplementation and One-Year Change in Mammographic Density in the Women's Health Initiative Calcium and Vitamin D TrialCancer Epidemiology, Biomarkers & Prevention, 21
-
J. Gerdes, Carsten Schlueter, M. Duchrow, C. Wohlenberg, C. Gerlach, I. Stahmer, Sabine, Kloth, E. Brandt, H. Flad (1991)
Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.The American journal of pathology, 138 4
-
S. Hadad, T. Iwamoto, L. Jordan, C. Purdie, S. Bray, L. Baker, G. Jellema, S. Deharo, D. Hardie, L. Pusztai, S. Moulder-Thompson, J. Dewar, Alastair Thompson, Alastair Thompson (2011)
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trialBreast Cancer Research and Treatment, 128
-
D. Macis, S. Gandini, A. Guerrieri-Gonzaga, H. Johansson, P. Magni, M. Ruscica, M. Lazzeroni, D. Serrano, M. Cazzaniga, S. Mora, I. Feroce, M. Pizzamiglio, M. Sandri, M. Gulisano, B. Bonanni, A. Decensi (2012)
Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 2
-
N. Bundred, A. Cramer, Julie Morris, L. Renshaw, K. Cheung, P. Flint, Rachael Johnson, O. Young, G. Landberg, S. Grassby, L. Turner, A. Baildam, L. Barr, Michael Dixon (2010)
Cyclooxygenase-2 Inhibition Does Not Improve the Reduction in Ductal Carcinoma In situ Proliferation with Aromatase Inhibitor Therapy: Results of the ERISAC Randomized Placebo-Controlled TrialClinical Cancer Research, 16
-
Tessa Cigler, Dongsheng Tu, Martin Yaffe, B. Findlay, Shailendra Verma, Dianne Johnston, Harriet Richardson, Haiqing Hu, S. Qi, Paul Goss (2010)
A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal womenBreast Cancer Research and Treatment, 120
-
E. Mylona, K. Tzelepis, I. Theohari, I. Giannopoulou, C. Papadimitriou, L. Nakopoulou (2013)
Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotypeHistopathology, 62
-
E. Schernhammer, J. Holly, M. Pollak, S. Hankinson (2005)
Circulating Levels of Insulin-like Growth Factors, their Binding Proteins, and Breast Cancer RiskCancer Epidemiology Biomarkers & Prevention, 14
-
Tessa Cigler, Harriet Richardson, Martin Yaffe, Carol Fabian, Dianne Johnston, J. Ingle, E. Nassif, R. Brunner, M. Wood, J. Pater, Haiqing Hu, S. Qi, Dongsheng Tu, Paul Goss (2011)
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal womenBreast Cancer Research and Treatment, 126
-
J. Wolfe (1976)
Risk for breast cancer development determined by mammographic parenchymal patternCancer, 37
-
Illian, D. S., Ite, Allas, E. R., Nglish, Argaret, M. R.E., Redie, Raham, G. G., Ilès, Avid, Ritchler, Artin, Y. J, affe, ohn, H. L., Opper (2002)
HERITABILITY OF MAMMOGRAPHIC DENSITY, A RISK FACTOR FOR BREAST CANCER -
S. Conroy, C. Woolcott, Karin Koga, C. Byrne, C. Nagata, G. Ursin, C. Vachon, M. Yaffe, I. Pagano, G. Maskarinec (2012)
Mammographic density and risk of breast cancer by adiposity: An analysis of four case‐control studiesInternational Journal of Cancer, 130
-
A. Shaaban, J. Sloane, C. West, C. Foster (2002)
Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.The American journal of pathology, 160 2
-
C. Fabian, B. Kimler, C. Zalles, J. Klemp, B. Petroff, Q. Khan, P. Sharma, K. Setchell, Xueheng Zhao, T. Phillips, T. Metheny, J. Hughes, H. Yeh, Karen Johnson (2010)
Reduction in Ki-67 in Benign Breast Tissue of High-Risk Women with the Lignan Secoisolariciresinol DiglycosideCancer Prevention Research, 3
-
G. Greendale, B. Reboussin, S. Slone, C. Wasilauskas, M. Pike, G. Ursin (2003)
Postmenopausal hormone therapy and change in mammographic density.Journal of the National Cancer Institute, 95 1
-
L. Kelemen, V. Pankratz, T. Sellers, K. Brandt, Alice Wang, C. Janney, Z. Fredericksen, J. Cerhan, C. Vachon (2008)
Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study.American journal of epidemiology, 167 9
-
A Urruticoechea, IE Smith, M Dowsett (2005)
Proliferation marker Ki-67 in early breast cancerJ Clin Oncol, 23
-
L. Reimers, D. Hershman, M. Maurer, K. Kalinsky, L. Brafman, G. Kranwinkel, K. Crew (2011)
Abstract A48: Pitfalls of using breast magnetic resonance imaging (MRI) in an early-phase breast cancer chemoprevention trial of vitamin D among high-risk postmenopausal womenCancer Prevention Research, 4
-
N. Boyd, G. Lockwood, L. Martin, J. Knight, J. Byng, M. Yaffe, D. Tritchler (1998)
Mammographic densities and breast cancer risk.Breast disease, 10 3-4
-
J. Cuzick, J. Warwick, E. Pinney, R. Warren, S. Duffy (2004)
Tamoxifen and breast density in women at increased risk of breast cancer.Journal of the National Cancer Institute, 96 8
-
Tong Li, Limei Sun, N. Miller, T. Nicklee, J. Woo, Lee Hulse-Smith, M. Tsao, R. Khokha, L. Martin, N. Boyd (2005)
The Association of Measured Breast Tissue Characteristics with Mammographic Density and Other Risk Factors for Breast CancerCancer Epidemiology Biomarkers & Prevention, 14
-
C. Fabian, B. Kimler, Juliet Anderson, O. Tawfik, M. Mayo, W. Burak, J. O’Shaughnessy, K. Albain, D. Hyams, G. Budd, P. Ganz, E. Sauter, S. Beenken, W. Grizzle, J. Fruehauf, D. Arneson, J. Bacus, M. Lagios, Karen Johnson, D. Browne (2004)
Breast Cancer Chemoprevention Phase I Evaluation of Biomarker Modulation by Arzoxifene, a Third Generation Selective Estrogen Receptor ModulatorClinical Cancer Research, 10
-
A. Decensi, C. Robertson, A. Guerrieri-Gonzaga, D. Serrano, M. Cazzaniga, S. Mora, M. Gulisano, H. Johansson, V. Galimberti, E. Cassano, S. Moroni, F. Formelli, E. Lien, G. Pelosi, Karen Johnson, B. Bonanni (2009)
Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 23
-
J. Eng-Wong, Jennifer Orzano-Birgani, C. Chow, D. Venzon, Jianhua Yao, C. Galbo, J. Zujewski, S. Prindiville (2008)
Effect of Raloxifene on Mammographic Density and Breast Magnetic Resonance Imaging in Premenopausal Women at Increased Risk for Breast CancerCancer Epidemiology Biomarkers & Prevention, 17
-
C. Stewart, P. Rotwein (1996)
Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors.Physiological reviews, 76 4
-
V. McCormack, I. Silva (2006)
Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysisCancer Epidemiology Biomarkers & Prevention, 15
-
A. Decensi, M. Puntoni, G. Pruneri, A. Guerrieri-Gonzaga, M. Lazzeroni, D. Serrano, D. Macis, H. Johansson, O. Pala, A. Luini, P. Veronesi, V. Galimberti, Maria Dotti, G. Viale, B. Bonanni (2011)
Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical TrialCancer Prevention Research, 4
-
K. Maruyama, H. Iso, Y. Ito, Yoshiyuki Watanabe, Y. Inaba, K. Tajima, K. Nakachi, A. Tamakoshi, M. Mori, F. Sakauchi, Y. Motohashi, I. Tsuji, Yosikazu Nakamura, H. Mikami, M. Kurosawa, Y. Hoshiyama, N. Tanabe, K. Tamakoshi, K. Wakai, S. Tokudome, S. Hashimoto, S. Kikuchi, Y. Wada, T. Kawamura, K. Ozasa, T. Miki, C. Date, K. Sakata, Y. Kurozawa, T. Yoshimura, Y. Fujino, A. Shibata, N. Okamoto, H. Shio (2009)
Associations of Food and Nutrient Intakes with Serum IGF-I, IGF-II, IGFBP-3, TGF-β1, Total SOD Activity and sfas Levels among Middle-aged Japanese: The JACC StudyAsian Pacific Journal of Cancer Prevention, 10
-
T. Nickerson, Hung Huynh, Michael Pollak (1997)
Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells.Biochemical and biophysical research communications, 237 3
-
S. Moschos, C. Mantzoros (2002)
The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical ApplicationsOncology, 63
-
J. Weitzel, S. Buys, W. Sherman, A. Daniels, G. Ursin, J. Daniels, D. Macdonald, K. Blazer, M. Pike, D. Spicer (2007)
Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 CarriersClinical Cancer Research, 13
-
NF Boyd, GA Lockwood, JW Byng, DL Tritchler, MJ Yaffe (1998)
Mammographic densities and breast cancer riskCancer Epidemiol Biomarkers Prev, 7
-
T. Key, P. Appleby, I. Barnes, G. Reeves, Endogenous Hormones (2002)
Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.Journal of the National Cancer Institute, 94 8
-
S. Niraula, R. Dowling, M. Ennis, Martin Chang, S. Done, N. Hood, J. Escallon, W. Leong, D. McCready, M. Reedijk, V. Stambolic, P. Goodwin (2012)
Metformin in early breast cancer: a prospective window of opportunity neoadjuvant studyBreast Cancer Research and Treatment, 135
-
C. Vachon, V. Suman, KathleenR. Brandt, M. Kosel, A. Buzdar, J. Olson, Fang-Fang Wu, L. Flickinger, G. Ursin, C. Elliott, L. Shepherd, R. Weinshilboum, P. Goss, J. Ingle (2013)
Mammographic Breast Density Response to Aromatase InhibitionClinical Cancer Research, 19
-
J. Cuzick, J. Warwick, E. Pinney, S. Duffy, S. Cawthorn, A. Howell, J. Forbes, R. Warren (2011)
Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.Journal of the National Cancer Institute, 103 9
-
R. DeFilippis, Hang Chang, N. Dumont, J. Rabban, Yunni-Yi Chen, G. Fontenay, H. Berman, M. Gauthier, Jianxin Zhao, D. Hu, J. Marx, J. Tjoe, E. Ziv, M. Febbraio, K. Kerlikowske, B. Parvin, T. Tlsty (2012)
CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues.Cancer discovery, 2 9
-
L. Vona-Davis, D. Rose (2007)
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.Endocrine-related cancer, 14 2
-
E. Garwood, E. Garwood, Anjali Kumar, Fl Baehner, D. Moore, A. Au, N. Hylton, C. Flowers, J. Garber, B. Lesnikoski, E. Hwang, O. Olopade, E. Port, M. Campbell, L. Esserman (2009)
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancerBreast Cancer Research and Treatment, 119
-
Timothy Key, Paul Appleby, Gillian Reeves, A. Roddam (2010)
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studiesThe Lancet. Oncology, 11
-
Jisun Kim, W. Han, H. Moon, S. Ahn, Heechul Shin, J. You, Sae-Won Han, S. Im, Tae-You Kim, H. Koo, J. Chang, N. Cho, W. Moon, D. Noh (2012)
Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancerBreast Cancer Research : BCR, 14
-
N. Boyd, Helen Guo, L. Martin, Limei Sun, J. Stone, E. Fishell, R. Jong, G. Hislop, A. Chiarelli, S. Minkin, M. Yaffe (2007)
Mammographic density and the risk and detection of breast cancer.The New England journal of medicine, 356 3
-
J. Stone, L. Willenberg, C. Apicella, S. Treloar, J. Hopper (2012)
The association between mammographic density measures and aspirin or other NSAID useBreast Cancer Research and Treatment, 132
-
M. Guix, N. Granja, I. Meszoely, Theresa Adkins, Bobbye Wieman, K. Frierson, V. Sanchez, M. Sanders, A. Grau, I. Mayer, G. Pestano, Y. Shyr, S. Muthuswamy, B. Calvo, H. Krontiras, I. Krop, M. Kelley, C. Arteaga (2008)
Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 6
-
R. Seshadri, A. Leong, Kieran McCaul, F. Firgaira, Vittal Setlur, D. Horsfall (1996)
Relationship between p53 gene abnormalities and other tumour characteristics in breast‐cancer prognosisInternational Journal of Cancer, 69
-
T. Jardé, F. Caldefie-Chézet, N. Gonçalves-Mendes, F. Mishellany, C. Buechler, F. Penault-Llorca, M. Vasson (2009)
Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.Endocrine-related cancer, 16 4
-
L. Martin, N. Boyd (2008)
Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidenceBreast Cancer Research : BCR, 10
-
A. Evans (1994)
Breast Imaging Reporting and Data SystemsThe Breast, 3
-
A. Renehan, M. Zwahlen, C. Minder, S. O'dwyer, S. Shalet, M. Egger (2004)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisThe Lancet, 363
-
M. Dowsett, N. Bundred, A. Decensi, R. Sainsbury, Yili Lu, M. Hills, F. Cohen, P. Veronesi, M. O'Brien, T. Scott, D. Muchmore (2001)
Effect of raloxifene on breast cancer cell Ki67 and apoptosis: a double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 10 9
-
Ann Thor, Shuqing Liu, Dan Moore, S. Edgerton (1999)
Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 2
-
W. Dupont, D. Page (1985)
Risk factors for breast cancer in women with proliferative breast disease.The New England journal of medicine, 312 3
-
C. Fabian, B. Kimler, C. Zalles, Q. Khan, M. Mayo, T. Phillips, Marie Simonsen, T. Metheny, B. Petroff (2007)
Reduction in proliferation with six months of letrozole in women on hormone replacement therapyBreast Cancer Research and Treatment, 106
-
K. Maruyama, H. Iso, Y. Ito, Yoshiyuki Watanabe, Y. Inaba, K. Tajima, K. Nakachi, A. Tamakoshi (2009)
Associations of food and nutrient intakes with serum IGF-I, IGF-II, IGFBP-3, TGF-b1, total SOD activity and sFas levels among middle-aged Japanese: the Japan Collaborative Cohort study.Asian Pacific journal of cancer prevention : APJCP, 10 Suppl
-
A. Wu, G. Ursin, W. Koh, Renwei Wang, Jian-Min Yuan, K. Khoo, Mimi Yu (2008)
Green Tea, Soy, and Mammographic Density in Singapore Chinese WomenCancer Epidemiology Biomarkers & Prevention, 17
-
N. Bundred, E. Anderson, R. Nicholson, M. Dowsett, M. Dixon, J. Robertson (2002)
Fulvestrant, an estrogen receptor downregulator, reduces cell turnover index more effectively than tamoxifen.Anticancer research, 22 4
-
L. Liberman, J. Menell (2002)
Breast imaging reporting and data system (BI-RADS).Radiologic clinics of North America, 40 3
-
B. Bonanni, M. Puntoni, M. Cazzaniga, G. Pruneri, D. Serrano, A. Guerrieri-Gonzaga, A. Gennari, Maria Trabacca, V. Galimberti, P. Veronesi, H. Johansson, Valentina Aristarco, F. Bassi, A. Luini, M. Lazzeroni, C. Varricchio, G. Viale, P. Bruzzi, A. Decensi (2012)
Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 21
-
Hai-feng Gao (2009)
Proliferation marker Ki-67 in early breast cancerJournal of Modern Oncology
-
Jan Merendonek, R. Keijzer, Cornelis Yelde, C. Cornelisse (1989)
Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells.Cancer research, 49 11
-
J. Heine, C. Scott, T. Sellers, KathleenR. Brandt, D. Serie, Fang-Fang Wu, M. Morton, B. Schueler, F. Couch, J. Olson, V. Pankratz, C. Vachon (2012)
A novel automated mammographic density measure and breast cancer risk.Journal of the National Cancer Institute, 104 13
-
Deborah Thompson, M. Leach, G. Kwan-Lim, S. Gayther, S. Ramus, I. Warsi, F. Lennard, M. Khazen, Emilie Bryant, S. Reed, C. Boggis, D. Evans, R. Eeles, D. Easton, R. Warren, The risk (2009)
Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS studyBreast Cancer Research : BCR, 11
-
M. Pollak (1998)
Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and preventionBreast Cancer Research and Treatment, 47
-
M. Dowsett, J. Dixon, Kieran Horgan, J. Salter, M. Hills, Eileen Harvey (2000)
Antiproliferative effects of idoxifene in a placebo-controlled trial in primary human breast cancer.Clinical cancer research : an official journal of the American Association for Cancer Research, 6 6
-
A. Basu, M. Du, K. Sanchez, M. Leyva, N. Betts, S. Blevins, Mingyuan Wu, C. Aston, T. Lyons (2011)
Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome.Nutrition, 27 2
-
Q. Khan, B. Kimler, A. O’Dea, C. Zalles, P. Sharma, C. Fabian (2007)
Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancerBreast Cancer Research, 9
-
M. Dowsett, I. Smith, S. Ebbs, J. Dixon, A. Skene, C. Griffith, I. Boeddinghaus, J. Salter, S. Detre, M. Hills, S. Ashley, S. Francis, G. Walsh (2005)
Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival.Clinical cancer research : an official journal of the American Association for Cancer Research, 11 2 Pt 2
-
J. Byng, M. Yaffe, R. Jong, R. Shumak, G. Lockwood, D. Tritchler, N. Boyd (1998)
Analysis of mammographic density and breast cancer risk from digitized mammograms.Radiographics : a review publication of the Radiological Society of North America, Inc, 18 6
- Publisher
- Springer Journals
- Copyright
- Copyright © 2013 by Springer Science+Business Media New York
- Subject
- Medicine & Public Health; Oncology; Internal Medicine; Surgical Oncology
- ISSN
- 1943-4588
- eISSN
- 1943-4596
- DOI
- 10.1007/s12609-013-0116-x
- Publisher site
- See Article on Publisher Site
Abstract
Breast cancer is the most common malignancy among women in the US, and prevention of this disease is therefore a major public health concern. Chemoprevention with anti-estrogens, including tamoxifen, raloxifene, and exemestane, has been shown to reduce the incidence of hormone receptor (HR)-positive breast cancer. However, breast cancer chemoprevention uptake has been poor and effective chemopreventive agents for HR-negative tumors are yet to be identified. A priority for breast cancer prevention research is improving the efficiency of chemoprevention trials by use of intermediate biomarkers correlated with breast cancer risk. This review provides an overview of the literature on breast-imaging-based, tissue-based, and circulating biomarkers which have been associated with breast cancer risk by observational studies and are being investigated as intermediate endpoints for early-phase chemoprevention trials.
Journal
Current Breast Cancer Reports – Springer Journals
Published: Jun 15, 2013